Medication info
Creameril M Tablet 2/500 mg

Creameril M Tablet 2/500 mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Shinpoong Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets/box [(10 tablets/PTP × 3)], 100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 201107231 · Notified 2011.09.27 · Insurance code 648506610

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg having been administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Ingredients

Manufacturer
Shinpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes by supplementing diet and exercise.

How to take

Adult dose

Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg having been administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Precautions

This medication may cause a risk of severe lactic acidosis or hypoglycemia, so it should be temporarily discontinued and a physician consulted in cases of sudden deterioration of kidney function or dehydration. It should not be used in patients with renal function below 45 mL/min/1.73 m2 and particular caution is necessary in situations where kidney function may change. Reports have associated this medication with increased mortality rates from cardiovascular diseases; therefore, patients should be adequately informed about the risks and benefits of the treatment. It should not be administered to patients with insulin-dependent diabetes, acute metabolic acidosis, severe liver dysfunction, pregnant women, breastfeeding women, or patients with severe kidney impairment. During the initial administration, the risk of hypoglycemia is high, so patients with poor nutritional status or excessive alcohol consumption should be monitored more closely. Gastrointestinal symptoms (diarrhea, nausea, vomiting, etc.) may commonly occur, and if symptoms are severe, administration may be temporarily discontinued. Allergic reactions, hematological abnormalities, and vitamin B12 deficiencies may occur; if abnormal symptoms appear, inform a physician immediately. While taking this medication, regular monitoring of blood sugar, kidney function, and blood tests should be performed. There may be interactions when used in combination with other medications, so patients should inform their physician or pharmacist of all medications they are taking. Pregnant or breastfeeding women should avoid using this medication, and insulin therapy should be initiated if needed. In the case of children or the elderly, dosage adjustment and careful monitoring are needed due to the possibility of decreased kidney function. In the event of overdose, hypoglycemia and lactic acidosis may occur; seek medical attention immediately for appropriate treatment. Caution is required when driving or operating machinery due to hypoglycemia or other side effects.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal bloating, loss of appetite, dyspepsia, constipation, abdominal pain, metallic taste, visual impairment, taste disorder, erythema, itching, hives, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, decreased vitamin B12, peripheral neuropathy, megaloblastic anemia, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, decreased thyroid-stimulating hormone levels, magnesium deficiency during diarrhea, encephalopathy, hair loss, weight gain, headache, severe hunger, fatigue, sleep, weakness, drowsiness, sleep disorders, instability, aggression, attention deficiency, inattention, abnormal reactions, depressive moods, confusion, speech disorders, aphasia, tremor, paralysis, sensory disturbances, dizziness, inability to self-regulate, delirium, cerebral seizures, loss of consciousness, coma, weak breathing, slow heart rate, sweating, moist skin, anxiety, rapid heart rate, hypertension, palpitations, angina, deep vein thrombosis, dizziness, liver dysfunction, prostate enlargement, palpitations, dizziness, leg swelling, cardiac arrest, rectal carcinoma, arthralgia, facial swelling, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air exposure and kept at room temperature between 1 degree and 30 degrees Celsius for safety. This helps maintain the medication's effectiveness and prevents degradation.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/box [(10 tablets/PTP × 3)], 100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.